Connect with us

News

Study Claims Cannabis Consumers May Need up to Twice the Amount of Anesthesia

Avatar

Published

on

Regular cannabis consumers may need twice the level of sedation while undergoing medical procedures, according to a new study published The Journal of the American Osteopathic Association. Not everyone, however, is convinced that the study makes any solid causal relationships between cannabis and anesthetics.

Investigators scoured through medical records of 250 patients that underwent procedures after Colorado legalized cannabis. Patients who smoked or ingested cannabis on a daily or weekly basis required 14 percent more fentanyl, 20 percent more midazolam, and 220 percent more propofol to achieve optimum sedation during medical procedures. There were however, only 25 patients out of the 250 participants who said they consumed cannabis regularly.

The investigators pointed out the problems of increased dosages of anesthetics. “Some of the sedative medications have dose-dependent side effects, meaning the higher the dose, the greater likelihood for problems,” lead researcher Mark Twardowski, said in a press release. “That becomes particularly dangerous when suppressed respiratory function is a known side effect.”

The team acknowledged the limited scope of the study results, and that a larger study is needed. “Cannabis has some metabolic effects we don’t understand and patients need to know that their cannabis use might make other medications less effective. We’re seeing some problematic trends anecdotally, and there is virtually no formal data to provide a sense of scale or suggest any evidence-based protocols,” Dr. Twardowski said.

But according to Dr. Roderic Eckenhoff, a professor of anesthesia at the University of Pennsylvania, the number of patients who were observed isn’t enough to make any solid correlations between cannabis and anesthesia. There were only 25 of the patients who said they smoked cannabis. In addition, calculations were all made based upon the patients’ own definition of what is “enough” anesthesia. Several individual factors between doctors and patients could have clouded the results. Eckenhoff and other scientists remain doubtful that a larger study would find 200 percent or more resistance to anesthesia in cannabis consumers.

 

News

Strain of the Week: Orange Cookies

Avatar

Published

on

January is known for a few things. First, New Year’s resolutions (that tend to fade in interest after about 30 days), second is honoring the legacy of Martin Luther King Jr., and of course, third is the annual return of Girl Scout Cookies. Having been in the cookie business since the 1920s, the Girl Scouts have consistently built up a cookie empire to help break countless Americans from their lofty goals of eating healthy and losing weight. This year, the organization unveiled a new cookie, called “Toast-Yay!” that offers a crunchy cinnamon flavor inspired by arguably the best breakfast foods—French Toast. While the hype for cookies is ever present, the year-long obsession with cookies-related strains is hard to beat.

There are numerous strains that are made famous through sporting the “Cookies” name, such as Orange Cookies. Not only identifiable as a flavor that the Girl Scouts organization doesn’t embrace (they offer some lemon flavors instead), but this strain also offers a beautifully light orange blossom scent as well. The large, dense buds that made up our sample of Orange Cookies was bright green, and nearly oozed trichomes by the look of the white sheen that covered its surface. As a result, it’s sticky in every sense of the word.

Upon inhalation, the smoke is smooth and pleasant, and brings on an interesting cerebral buzz that settles into full blown euphoria as it spreads throughout the body. While your muscles are soothed and relaxed of nearly all tension, your body is calm and relaxed—but that doesn’t mean that you will be completely sedated or disoriented. Orange Cookies not only has a unique flavor profile, but it also helps in alleviating symptoms of anxiety and depression for some consumers. It’s the perfect way to sit inside and count the days until a warm spring day arrives.

Continue Reading

News

Legal Cannabis Linked to Increase in Junk Food Sales

Avatar

Published

on

A look at the consumption habits of Americans has revealed that high-calorie food sales tend to increase in places where cannabis is legal.

Published in the journal Economics & Human Biology, a Georgia State University study examined the link between food sales of high-calorie and high-sugar snacks and in places where cannabis was legalized. Headed up by economist Alberto Chong and Michele Baggio, the study showed that junk food sales increased by 6.3 percent in sales when cannabis was legal in the region.

“You think marijuana does no harm—that’s pretty much the consensus today,” Chong told The Academic Times regarding the recently published study and the implications behind it. “But there are unintended consequences, and one of them is the fact that you really get very hungry and you start eating crap.”

The study looked at three states with legal cannabis, Colorado, Oregon and Washington. It compared cannabis data to the Nielsen Retail Scanner Data in those states before and after cannabis was legalized, looking for sales of junk food in drug stores, convenience stores, and grocery stores. It noticed a marked increase across the board following legalization.

The research was originally published in a paper in 2019, and recently released in a journal. Specific spikes in sales they tracked include chip sales increasing by 5.3 percent, cookie sales by 4.1 percent, and ice cream by 3.1 percent.

Those involved in the research product hope that these trends will be taken into consideration for future legalization ventures. Previous studies by Chong and Baggio looked at how cannabis increases sexual activity and raises the birth rate. Additionally, they tracked a decrease in alcohol sales due to cannabis legalization.

Statistical information about how cannabis impacts things like sexual activity, alcohol use and cannabis use are important to crafting the best policies for regulation as cannabis moves forward.

Continue Reading

News

Europe Cannabis Testing Market Expected to Reach $770 Million By 2027

Avatar

Published

on

The European cannabis testing market is expected to grow to a little over $770 million USD from $431.58 million in 2019. The market is expected to grow with a Compound Annual Growth Rate (CAGR) of 7.7 percent from 2020 to 2027.

A new report, “Europe Cannabis Testing Market to 2025 – Regional Analysis and Forecasts by Type ; Services ; End User and Country,” outlined the growth of the industry to 2025. The growth of the market can be attributed to the European government funding cannabis research for doctors as well as the increasing demand for researching cannabis quality. The report mentions non-medical uses of cannabis and problems with CBD oil products are likely to have a negative impact on the growing market.

The European cannabis testing market is split into three segments: testing laboratories, drug manufacturers and research institutes. In 2019, the testing laboratories held the largest share of the market and is expected to continue growing due to testing performed in the reference labs for various diseases.

In February 2019, members of the European Parliament (MEPs) passed a joint resolution supporting medical cannabis. The resolution allows doctors to use their best judgment in prescribing cannabis-based medicines, and calls on MEPs to address barriers that prevent cannabis research. The aim is to clearly distinguish between what is considered medical-use cannabis and what is considered non-medical.

Currently, there are no countries in the European Union that allow smoking cannabis or home-growing for medical purposes. The World Health Organization has previously recommended that CBD should not be classified as a controlled substance. The European Union has already approved a CBD-based medicine that helps treat severe seizures.

Continue Reading

Newsletter

Trending